Autolus Therapeutics Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Autolus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.73. The average 1-year stock price forecast is 306.05% higher than the current stock price, while the lowest is $5.00 (+132.56%) and the highest is $11 (+411.63%).

Price Target: $8.73 (+306.05%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$5.00	$8.73	$9.50	$11
Change	+132.56%	+306.05%	+341.86%	+411.63%

Analyst Ratings

The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	10	10	9	8	8	8
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	10	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Wells Fargo No rating	Wells Fargo	Buy Reiterates $5	Buy	Reiterates	$5	+132.56%	Aug 12, 2026
Rajan Sharma Goldman Sachs	Goldman Sachs	Buy Reiterates $5.4 → $5.8	Buy	Reiterates	$5.4 → $5.8	+169.77%	Aug 12, 2026
Matt Phipps William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Aug 11, 2026
Gil Blum Needham	Needham	Buy Reiterates $10	Buy	Reiterates	$10	+365.12%	Aug 11, 2026
Emily Bodnar H.C. Wainwright	H.C. Wainwright	Buy Maintains $10	Buy	Maintains	$10	+365.12%	Aug 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

149.75M

from 75.39M

98.64%

from 75.39M

Revenue Next Year

193.55M

from 149.75M

29.24%

from 149.75M

EPS This Year

-0.79

from -1.08

EPS Next Year

-0.64

from -0.79

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.33M	6.36M	1.70M	10.12M	75.39M	149.75M
Revenue Growth	35.86%	172.96%	-73.30%	496.00%	644.94%	98.64%
Operating Income	-140.37M	-142.89M	-175.53M	-241.01M	-270.20M	-189.04M
Net Income	-142.10M	-148.84M	-208.38M	-220.66M	-287.53M	-212.99M
EPS	-	-	-	-	-1.08	-0.79
Free Cash Flow	-77.76M	-75.76M	-125.13M	-206.33M	-249.40M	-117.90M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	155.4M
Avg	149.8M
Low	146.5M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	106.1%
Avg	98.6%
Low	94.3%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.69
Avg	-0.79
Low	-0.92

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-